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Comparison of allele frequencies 
of Plasmodium falciparum merozoite antigens 
in malaria infections sampled in different years 
in a Kenyan population
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Greg Fegan1, Philip Bejon1 and Kevin Marsh1
Abstract 
Background: Plasmodium falciparum merozoite antigens elicit antibody responses in malaria‑endemic populations, 
some of which are clinically protective, which is one of the reasons why merozoite antigens are the focus of malaria 
vaccine development efforts. Polymorphisms in several merozoite antigen‑encoding genes are thought to arise as a 
result of selection by the human immune system.
Methods: The allele frequency distribution of 15 merozoite antigens over a two‑year period, 2007 and 2008, was 
examined in parasites obtained from children with uncomplicated malaria. In the same population, allele frequency 
changes pre‑ and post‑anti‑malarial treatment were also examined. Any gene which showed a significant shift in 
allele frequencies was also assessed longitudinally in asymptomatic and complicated malaria infections.
Results: Fluctuating allele frequencies were identified in codons 147 and 148 of reticulocyte‑binding homologue 
(Rh) 5, with a shift from HD to YH haplotypes over the two‑year period in uncomplicated malaria infections. However, 
in both the asymptomatic and complicated malaria infections YH was the dominant and stable haplotype over the 
two‑year and ten‑year periods, respectively. A logistic regression analysis of all three malaria infection populations 
between 2007 and 2009 revealed, that the chance of being infected with the HD haplotype decreased with time from 
2007 to 2009 and increased in the uncomplicated and asymptomatic infections.
Conclusion: Rh5 codons 147 and 148 showed heterogeneity at both an individual and population level and may be 
under some degree of immune selection.
Keywords: Rh5, Merozoite, Plasmodium, Malaria
© 2016 Ochola‑Oyier et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International 
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any 
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons 
license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.
org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Genes involved in immune interactions tend to contain 
adaptive variation that is maintained by balancing selec-
tion [1, 2]. In Plasmodium falciparum balancing selection 
is evidenced by the presence of multiple polymorphisms 
in several merozoite antigens, such as merozoite sur-
face protein-1 (MSP-1) [3], apical membrane antigen-1 
(AMA-1) [4], erythrocyte binding antigen-175 (EBA-175) 
[5], MSP3 [6], MSP Duffy Binding Ligand-1 (DBL-1) [7], 
MSPDBL2 [8], reticulocyte binding homologues Rh2a 
and Rh2b [9, 10].
Since merozoite proteins are targets of host immunity 
[10–13] polymorphisms are thought to be maintained 
by selection from host immune responses. There is evi-
dence to suggest polymorphisms could result in primarily 
allele-specific immune responses [6, 14, 15]. Therefore, 
an individual may resist infection to one parasite allele 
for which they have pre-existing immunity but not to a 
heterologous allele that they have not yet encountered. 
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Initially over time, rare alleles attracting less ‘immune 
attention’ would be expected to progressively proliferate 
while dominant alleles are cleared by the immunity they 
induce [16]. Thus, the polymorphisms are potentially 
maintained by a mechanism of frequency-dependent 
selection. Allele-specific immunity may limit the efficacy 
of vaccines developed against the merozoite blood stage 
antigens [17–19].
Stable balancing selection predicts constant interme-
diate allele frequencies over long periods [20], which 
change more slowly over time than they would under 
neutral genetic drift (2). This has been demonstrated in 
merozoite antigens in longitudinal studies, which pri-
marily assessed repeat regions in MSP1 and MSP2 alleles 
[16, 21–24]. Similar observations were made with other 
merozoite antigens SURFIN4.1 [25], SURFIN4.2 [26] 
and GLURP [27]. In contrast, under fluctuating selection 
due to spatial and temporal variation, allele frequen-
cies dynamically change over time becoming common 
when advantageous and rare when disadvantageous [28, 
29], and allele frequencies should change more quickly 
over time than they would under neutral genetic drift 
[2]. There are a few cases where some merozoite antigen 
polymorphisms fluctuate in frequency over time [16, 21, 
30, 31].
The basis of the frequency-dependent selection oper-
ating on merozoite antigens is not entirely understood. 
It is likely to reflect both the function of merozoite 
antigens as invasion receptors (erythrocyte-merozoite 
interactions) and the impact of the immune system on 
the merozoite. Understanding the distribution of mero-
zoite antigen polymorphisms in natural parasite popula-
tions can inform the vaccine design process. The main 
aim of this study was to analyse the allele frequency 
distribution of 15 merozoite antigens in uncomplicated 
malaria infections from children under 5 years of age in 
an endemic area in Kilifi, Kenya over a two-year period, 
in order to identify single nucleotide polymorphisms 
(SNPs) under selection. Any significantly fluctuating 
SNPs were then investigated in asymptomatic and com-
plicated malaria infections. Two SNPs (codons 147 and 
148) in Rh5 were identified, which significantly fluctu-
ated over the two-year period in uncomplicated malaria 
infections and remained stable in the asymptomatic and 
complicated malaria infections. Within the same popu-
lation (the children under 5 years of age with uncompli-
cated malaria) the changes in allele frequencies pre- and 
post-anti-malarial treatment were also studied. Rh5 
codons 147 and 148 were more likely to change during 
the course of an infection pre- and post-drug treatment. 
Additionally, the extent of genetic diversity was exam-
ined within and between the genes usling linkage dis-
equilibrium (LD).
Methods
Longitudinal Plasmodium falciparum population samples
Merozoite antigenic diversity was examined by geno-
typing 15 genes (see Additional file  1) in 100 para-
sites obtained from children aged up to five years 
with uncomplicated malaria, between 2007 (n  =  62) 
and 2008 (n  =  38), recruited into a randomized, con-
trolled trial of dihydroartemisinin-piperaquine versus 
artemether–lumefantrine in Pingilikani sub-location, 
Kilifi County (Trial registration: Controlled-Trials.com 
ISRCTN88705995) [32]. Any gene that showed a sig-
nificant temporal change in allele frequency was also 
sequenced in three other parasite populations (to deter-
mine if the change was observed in other malaria infec-
tion populations): (1) asymptomatic malaria infections 
from an annual community survey of parasite-positive 
children aged up to 12 years; 266 cross-sectional venous 
bleed samples were obtained before the malaria season 
in 2007 (n = 108), 2008 (n = 104) and 2009 (n = 54) in 
Junju sub-location, Kilifi County, Kenya. Junju and Pin-
gilikani are generally high to moderate transmission 
areas, although transmission is falling in Kilifi County 
as a whole [33]. Pingilikani and Junju neighbour each 
other and the dispensaries are at least 10  km apart; (2) 
300 isolates taken from parasite-positive children aged 
up to 12  years admitted to the Kilifi District Hospital 
(KDH) between 2007 and 2009 (100 isolates each year). 
This was later extended to 100 samples each over a ten-
year period from 2000 to 2010. These samples were 
defined as complicated malaria infections and were also 
representative of the parasite population in Kilifi County 
since KDH serves a population within an 891  km2 area 
of 15 administrative locations within the Kilifi Health and 
Demographic Surveillance System (KHDSS) [34]; and, 
(3) 11 genotypically distinct laboratory isolates obtained 
from geographically diverse P. falciparum sources (3D7, 
cloned from an airport malaria case in The Netherlands; 
RO33 and Palo Alto, from Africa; K1, Dd2, FCC2 and 
D10, V1/S from Southeast Asia; Wellcome, nominally 
from Africa but suspected to have been previously cross-
contaminated by parasites of unknown source during 
culture; HB3 from Honduras and IT from Brazil). Para-
site DNA was extracted from packed frozen erythrocytes 
using the QIAamp DNA Blood Mini Kit (QIAGEN, UK).
Pre‑ and post‑drug treatment Plasmodium falciparum 
samples
The uncomplicated malaria samples were obtained from 
the randomized, controlled drug trial described above. 
The pre-treatment sample (day 0) was obtained on 
recruitment of a child into the study. The children were 
followed up weekly until day 63 and finally on day 84, 
resulting in a post-treatment sample (range 19–84 days, 
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mean number of days = 50) if a child was parasite slide-
positive during a follow-up visit. The samples were previ-
ously genotyped using MSP1, MSP2 and glutamate-rich 
protein (GLURP) [32] and a large majority of the post-
treatment samples were re-infections (about 64  %) and 
8  % were recrudescent infections the remaining were 
indeterminate. Parasite genomic DNA was extracted 
from dried filter-paper blood spots using the boiling 
method described elsewhere [35]. Briefly, this involved 
snipping a small piece of the dried filter paper, fixing it 
in methanol and boiling at 100 °C in TB Elution buffer to 
extract the DNA. All the above studies were reviewed and 
approved by the Scientific Steering Committee and the 
Ethics Committee of the Kenya Medical Research Insti-
tute. Consent for study participation was obtained from 
the parents or legal guardian of the study participants.
PCR and sequencing of polymorphic Plasmodium 
falciparum genes
The 15 merozoite antigens were amplified using High 
Fidelity Taq polymerase (Roche) (details of regions 
amplified and primers are shown in Additional file  1). 
PCR-generated products were visualized on 1 % agarose 
gels, purified using ethanol precipitation and directly 
sequenced using the PCR primers, additional sequencing 
primers, BIG DYE terminator chemistry v3.1 (Applied 
Biosystems, UK) and an ABI 3130xl capillary sequencer 
(Applied Biosystems, UK). Nucleotide positions which 
displayed a peak within a peak in the electropherogram 
were defined as a mixed base and excluded from further 
analysis. Sequences were assembled, edited and aligned 
using SeqMan and MegAlign (DNASTAR, Madison, WI, 
USA). SNPs were identified and using their correspond-
ing amino acids, haplotypes were defined.
Statistical analysis of longitudinal Plasmodium falciparum 
polymorphic genes
To analyse SNP frequency dynamics in the 15 mero-
zoite genes, comparisons were conducted within the 
uncomplicated malaria parasite population for SNPs 
that showed a significant temporal shift (between 2007 
and 2008) using the Fisher’s exact test. SNPs with a >5 % 
minor allele frequency (MAF) were translated into their 
corresponding amino acids, in order to define haplotypes, 
which were also analysed. Any gene which maintained 
significance after a Bonferroni correction for multi-
ple comparisons [36] was analysed further for temporal 
allele frequency changes in a primarily asymptomatic 
malaria parasite population between 2007 and 2009, and 
in a complicated malaria parasite population obtained 
from KDH between 2007 and 2009. A logistic regression 
analysis was performed on all the three parasite popula-
tions, controlling for year, age and population. Each gene 
was then examined for allele frequency changes over a 
ten-year period in the KDH sample set. Within the ten-
year complicated malaria infection samples, the homo-
geneity of the infected population was determined and 
investigated if there were any linear trends of location, 
age and severe malaria syndrome, coma, deep breath-
ing, and anaemia [37] using the ‘tabodds’ command in 
Stata. All analyses were conducted using Stata v11 (Stata-
Corp, TX, USA) and R. Using the available latitude and 
longitude co-ordinates, the Rh5 haplotypes from the 
uncomplicated (Pingilikani), asymptomatic (Junju) and 
complicated (KDH) malaria parasite populations were 
plotted on to the KHDSS map [34]. The spatial scan sta-
tistic (SaTScan) software [38] was then employed as in 
Bejon et al. [39], to identify significant haplotype clusters, 
using a Bernoulli (case–control) model to test for signifi-
cant clusters between the two dominant haplotypes and a 
multinomial model to test between all the haplotypes in 
each of the parasite populations between 2007 and 2009.
Statistical analysis of pre‑ and post‑drug treatment 
Plasmodium falciparum polymorphic genes
The overall population proportions of merozoite gene 
allelic pairs which were the same and different pre- and 
post-treatment from the same individual were deter-
mined. The parasite pairs were defined using haplotypes 
consisting of the amino acid codes for genes (rh1, rh5, 
eba140, ebl-1, msp142) with a maximum of six SNPs and 
in genes (rh2a, rh2b, rh4, eba175, eba181, ama1, msp3, 
msp6, mspdbl1, mspdbl2), containing greater than six 
SNPs we assessed individual SNPs. The number of hap-
lotype changes per parasite pair, pre- and post-treatment, 
were determined for each gene. A non-parametric test 
(McNemar’s test) for matched paired data was then done 
to analyse the proportion of heterologous compared to 
homologous haplotypes at each locus. Mixed infections 
were excluded from the analysis. To determine whether 
SNPs were in LD, all possible pair-wise comparisons 
between SNPs across all the genes were performed using 
a pair-wise correlation analysis with a Bonferroni correc-
tion for multiple comparisons [36].
Results
Merozoite gene haplotype frequencies in the 
uncomplicated malaria infections between 2007 and 2008
Most haplotypes were present as stable frequencies over 
the two-year period. There were two dominant hap-
lotypes for EBL1-QFFFF.VN and QLFLSKS, EBA181-
NKSFN and NQSFN and EBA140-VSTK and INTK; 
the 3D7 reference EBA140 haplotype, INKK, was not 
observed in this population (see Additional file 2). The 5′ 
end of the MSP1 42 kDa sequence contained a 3-bp dele-
tion which has not been described before (SNP4414-6), 
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resulting in three stable and high frequency haplotypes, 
FKFFDD (3D7 reference), FKFFDN, FFFDD. MSP3 K1 
and MSP6 3D7 were the prevalent and stable haplo-
types. The MSPDBL1 and MSPDBL2 haplotypes were 
defined as previously described [40]. Shifts in haplo-
type frequencies were observed in MSPDBL1 from 
AHQIARY to ALTAIKY, and for MSPDBL2, AHQAIRY 
was the dominant haplotype in both years. The variation 
in the Rh family was characterized by assessing previ-
ously defined polymorphic regions (see Additional file 1) 
[41]. The C-terminal end of Rh1 included two dipeptide 
(HNQN) repeats. The common dipeptide repeats rep-
resented the 3D7 reference sequence, 4HNQN, which 
shifted to 3HN2QN in 2008 and 4HN2QN remained 
stable over the two years. Rh2a and Rh4 both con-
tained as the stable and widespread genotype the 3D7 
reference haplotypes, KAKQQR and (IHTNENNINN)
(EHTNENNINN)(EHTNEKNINN)(EHANEKNIYN)
(EHTNENNINY), respectively. In Rh2b, two previously 
described deletions, a 192-bp deletion (codon 2717) [42] 
and a 585-bp deletion (codon 2954) [42, 43] were iden-
tified. The 156-bp insertion, Q (codon 2795) and a 585-
bp deletion (156insQ585del) was dominant and stable, 
while 156del585del and 192ins585del were only present 
at high frequency in 2007 and 2008, respectively. The 
3D7 reference genotype, 156ins585ins, was not observed 
in this population. A shift was also observed in Rh5 
from N(DYKNVDYKNV)HDY to N(DYKNVDYKNV)
YHY. The previously described EBA175 6-bp dele-
tion [5] was identified and distinct fluctuations in the 
haplotypes from EEKKSISENKKI to EKEKPISEN-
KKK between 2007 and 2008 were observed. AMA1 
was defined using the amino acids in cluster 1 loop 
of domain I (codons 196, 197, 199, 200, 201, 204, 206, 
207) [44], DQRHFDKY (16  %) and NGRDLNEY (14  %) 
were the two high frequency haplotypes. Sequences 
for all 15 genes were submitted to GenBank and are 
available under the accession codes EBL1:KU525776–
KU525801, MSP6:KU525802–KU525809, KU525811, 
KU525813–KU525817, KU525819, KU525822–KU525844, 
Rh2b:KU525845–KU525879, Rh5:KU525880–KU525986, 
Rh2a:KU525988–KU526029, MSPDBL1:KU526030–KU52 
6063, EBA140:KU526064–KU526129, Rh1:KU526130–KU 
526176, MSPDBL2:KU526177–KU526235, EBA175: 
KU526236–KU526265, EBA181:KU526266–KU526296, 
Rh4:KU526297–KU526361, MSP1:KU526362–KU526442, 
Rh5_10yr_samples: KU526443–KU526857 and KU526859– 
KU526963, AMA1:KU526964–KU527018, MSP3: 
KU527019–KU527058.
Genetic diversity pre‑ and post‑treatment
Apart from ama1, msp1, eba175, mspdbl2, mspdbl1 and 
rh2b SNPs, which were 100  % different parasite pairs, 
though the latter two genes included an analysis of three 
pairs, in the rest of the genes the number of parasite pairs 
that were the same were <50 %. However, Rh4 (68 %) and 
Rh5 (70 %) (see Additional file 3) contained a larger num-
ber of parasite pairs that were the same. Only Rh5 showed 
a significant (McNemar’s χ2  =  4, p  =  0.046) change in 
haplotype frequencies with an increased odds (OR 1.3, 
95 % CI 1–1.7) of different haplotype parasite pairs com-
pared to the same pairs (Table 1) pre- and post-treatment.
Linkage disequilibrium analysis
A LD analysis was conducted for all genes except eba181, 
which had very few SNPs to analyse. Within gene analy-
sis, all genes contained SNPs in LD except rh1, the indels 
in msp1, eba175, ebl-1 and rh2b, the repeat region of rh4, 
SNPs 439 and 442 in rh5, SNPs 553 and 716 in eba140 
and multiple SNPs across the ama1 gene (see Addi-
tional file 4). There are potential recombination hot spots 
between the two LD blocks in rh2a at the 5′ and 3′ ends 
of the sequenced region, the major LD block towards the 
5′ end and a smaller LD block towards the 3′ end of msp-
dbl2 and the small LD block at the 5′ end followed by a 
large central LD block and a minor LD block towards the 
3′ end of mspdbl1. SNPs in LD between genes were iden-
tified (see Additional file 4); mspdbl2, the gene with the 
most SNPs (>200) showed the largest number of between 
gene LD, with SNPs in LD with six other genes, eba140, 
eba175, rh4, ama1, msp3 and mspdbl1. SNPs in mspdbl1, 
msp3 and ama1 were in LD with five other genes, rh2a 
and eba175 with four genes, msp6 and eba140 with two 
genes and ebl-1, rh2b, msp1, rh4 and rh1 with only one 
gene. Of interest, rh5 SNP 608 appears to be in LD with 
eba175 SNP 1434 and rh5 SNP 442 with rh2a SNPs 8459, 
8460, 8463, 8464, and 8465. A summary of the between-
gene LD SNP analysis is depicted in Fig. 1.
Frequency distribution of the merozoite gene 
polymorphisms in the uncomplicated malaria infections 
between 2007 and 2008
A large majority of the SNPs were stably maintained 
over the two-year period. Eight genes contained some 
SNPs which showed significant (p < 0.05) temporal fluc-
tuations (heterogeneity), Rh1–QN repeat, MSP3–SNPs 
219 and 1029, MSPDBL2–SNPs 580 and 587, EBA175- 
SNPs 1168, 1750 and 1990, AMA1–SNPs 724, 727, 799 
and 922 and MSPDBL1 contained a group of about 85 
SNPs which were in LD between SNPs 467 and 855, of 
which SNPs downstream from SNP524 had a p value of 
0.008. There were very few SNPs with a p value  <0.01, 
Rh2b–SNP 8149 (192  bp indel), EBA175–SNP1442 and 
AMA1–SNP1478. Only the Rh5 SNPs 439 and 442 were 
highly significant, p = 0.00011 (see Additional file 5) and 
remained significant after a Bonferroni correction.
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Distribution of PfRh5 polymorphisms in all three malaria 
infection populations
Rh5 codons 48, 197, 203, and 204 were identified in the 
11 cultured isolates (see Additional file 6), identifying the 
previously described codons by Hayton and colleagues 
[45]. Only codons 197 and 203 were observed in the 
Kilifi population, however, codon 197 was a singleton 
SNP in the asymptomatic infections. In the uncompli-
cated malaria infections, two other rare variants, three 
DYKNV repeats (codon 132) in two isolates instead of 
Table 1 McNemar’s χ2 test of haplotype proportions from pre- and post-treatment parasite pairs
italic value indicates a significant increase in the odds of the Rh5 haplotypes changing compared to staying the same between parasite pairs before and after 
treatment
Other represents genes with more than 2 high frequency haplotypes, the dominant allele was compared to all other alleles in the population, ND not determined, No 
data insufficient pairs for the analysis <4
Pre‑ and post‑treatment
Pre Post McNemar’s χ2 (p value) OR (95 % CI)
AMA1 DQRHFDKY Other
DQRHFDKY 0 0
Other 2 8 2 (0.16) ND
EBA140 VSTK Other
VSTK 5 2
Other 3 5 0.2 (0.65) 0.9 (0.5–1.6)
EBA181 Q K
Q 5 4
K 2 2 0.67 (0.41) 1.3 (0.7–2.4)
EBA175 EKEKPISENKKK Other
EKEKPISENKKK
Other No data
EBL‑1 QFFFF.VN Other
QFFFF.VN
Other No data
MSP1 KD Other
KD 7 2
Other 5 3 1.29 (0.26) 0.8 (0.5–1.2)
MSP3 K1 3D7
K1 4 2
3D7 3 0 0.2 (0.65) 0.9 (0.4–1.7) 
MSP6 K1 3D7
K1 1 2
3D7 3 9 0.2 (0.65) 0.8 (0.2–2.7)
MSPDBL1 ALTAIKY Other
ALTAIKY
Other No data
MSPDBL2 AHQAIRY Other
AHQAIRY 2 6
Other 7 3 0.08 (0.78) 0.9 (0.4–2.0)
Rh1 4HN2QN Other
4HN2QN 1 2
Other 1 3 0.33 (0.56) 1.5 (0.4–6.0)
Rh2b 156insQ585del Other
156insQ585del
Other No data
Rh5 HD YH
HD 13 4
YH 0 3 4 (0.046) 1.3 (1.0–1.7)
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the common 3D7 haplotype of DYKNVDYKNV (two 
repeats) and a singleton at SNP262 (codon 88) were 
observed. Furthermore, two additional high frequency 
SNPs in codons 147 and 148 were identified that were not 
observed in the laboratory isolates. Codons 147 and 148 
were previously described in the MalariaGen data [46, 
47]. These codons resulted in two haplotypes, YH and the 
non-reference 3D7 haplotype HD. A rare combination of 
YD was also observed in the complicated malaria infec-
tions. There were two high frequency, stable haplotypes 
in the asymptomatic infections YHSY and HDSY with 
YHSY being dominant over the two-year period from 
2008 to 2009. After multiple attempts, we were unable 
to obtain PCR amplicons from the 2007 samples. The 
YHY and HDY haplotypes were prevalent and YHY was 
the dominant and stable haplotype in the complicated 
malaria infections from 2007 to 2009.
PfRh5 analysis in all three malaria infection populations
The uncomplicated, asymptomatic and complicated malaria 
infections were compared between the years 2007–2009. 
Though we excluded mixed infections over this time period, 
we noticed that the number of mixed infections in the 
uncomplicated and complicated malaria infections were 6 % 
(n = 44) and 5 % (n = 150), respectively, about fourfold lower 
than asymptomatic malaria infections (24  %, n =  54). The 
analysis focused on the two dominant codons 147 and 148, 
which showed a highly significant shift in haplotype frequen-
cies between 2007 and 2008 (p = 0.00011), from HD to YH 
in the uncomplicated malaria infections (Fig. 2). In contrast, 
there was a dominance of the YH haplotype over the two-
year period in the asymptomatic infections (p =  0.19) and 
over the three-year period (2007–2009) in the complicated 
malaria infections (p  =  0.16). Interestingly, in the uncom-
plicated malaria infections there was a significant difference 
between the mean ages 2.5 and 3.5 in 2007 and 2008, respec-
tively (t test unequal, p = 0.0007). However, there was no sig-
nificant difference in the asymptomatic infections between 
2008 and 2009 (mean age 6.4 and 6.6, respectively, t test 
unequal, p = 0.51) and in the complicated malaria infections 
(mean age three in all years, t test unequal, p = 0.96). The 
significant shift in haplotypes in the uncomplicated malaria 
infections may be due to the significant mean age difference 
between the years. However, a logistic regression analy-
sis suggested age had no effect on the infecting Rh5 haplo-
types, but the chance of being infected with HD parasites 
decreased with time from 2007 to 2009 and the probability 
of HD infections increased moving from uncomplicated to 
Fig. 1 Summary of linkage disequilibrium (LD) analysis depicting 14 merozoite antigens that contain SNPs in LD between genes. The blues lines 
indicate genes with SNPs in LD with ama1, red those in LD with mspdbl2, purple mspdbl1, green msp3, black eba175 and brown rh2a and rh5 have 
SNPs in LD with each other. The gene in a specific column is in LD with other genes as depicted by the lines and the number of genes each gene is in 
LD with is shown in the boxes
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asymptomatic malaria infections (Table 2). Also, there were 
no significant haplotype frequency differences between 2008 
and 2009 in uncomplicated and asymptomatic infections. 
The haplotypes from 2007 to 2009 were plotted on to the 
KHDSS map (Fig. 3) to examine geographical clustering of 
haplotypes. Altogether SaTScan did not pick out any signifi-
cant haplotype (YH or HD) clusters. However, a within-year 
stratification picked out a significant cluster in the north of 
the district with more YH infecting parasites when com-
pared to all other possible clusters in 2007 (relative risk = 2, 
p = 0.0024) (Fig. 3b).
Stable Rh5 polymorphisms over a ten‑year period 
of declining malaria transmission
The stable haplotype frequencies of a dominant YHY hap-
lotype, followed by HDY and YHC haplotypes observed 
between 2007 and 2009, extended over a ten-year period 
from 2000 to 2010. On occasion rare variants, HDC, were 
observed in 2000, 2005, 2009 and 2010 and also YDY in 
2008, 2009 and 2010 (Fig. 4). There is evidence of a lack of 
homogeneity (p = 0.0001) and a linear trend (p < 0.001) 
of an increase in the odds of individuals admitted to KDH 
coming from the south of the district and from an older 
age group,  >5  years (p =  0.02 and 0.0016, respectively) 
over the ten-year period. Consequently, the increase in 
the number of cases from the south is associated with 
increase in the age of the children admitted to KDH. 
This population of individuals with complicated malaria 
had at least one of the severe malaria syndromes of deep 
breathing, anaemia (haemoglobin  <5  g/dl) and cerebral 
malaria (Blantyre coma score <3) [37]. Over the ten-year 
period there is evidence of a linear trend of a decrease in 
the odds of cerebral malaria (p = 0.0004), there is a lack 
of homogeneity in the odds of population exhibiting deep 
breathing (p =  0.002), and there were no differences in 
the individuals with anaemia. However, when location 
and age were adjusted for in the analysis there were no 
trends observed in any of the severe malaria syndromes.
Discussion
The stable and intermediate allele frequencies of all genes 
except Rh2a and Rh4 (which had only one dominant 
allele from the region sequenced) are suggestive of these 
polymorphisms being maintained by stable balancing 
selection. In particular, the antigens which have previ-
ously shown evidence of being under balancing selection 
in cross-sectional population studies such as AMA1 [11, 
48], MSPDBL1 [7], MSPDBL2 [8], and MSP3 [6]. The 
stable alleles are being maintained by a constant selec-
tion pressure on these antigens obtained from parasites, 
resulting in uncomplicated malaria in children under the 
age of five over a two-year period.
Though it does not seem to matter if an individual is 
infected with the YH or HD alleles, what was striking 
was the shift in allele frequencies observed only in Rh5. 
This suggests that Rh5 may be under different selection 
pressures over the two-year period examined, resulting 
in fluctuating allele frequencies. At an individual level, 
what appeared to be frequency-dependent selection 
was observed in the pre- and post-treatment infections 
in only Rh5. All the changes were from pre-treatment 
HD infections to YH post-treatment infections. The 
Rh5 codons 147 and 148 showed a greater likelihood 
of changing compared to staying the same. In vaccine-
induced selection, subsequent infections post-vaccine 
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Fig. 2 The distribution of Rh5 high frequency haplotypes, YH and HD, 
in all three malaria infections. The uncomplicated malaria infections 
from 2007 to 2008 showed a significant shift in haplotype frequency 
from HD to YH in 2008 (p = 0.00011). However, in the asymptomatic 
malaria infections between 2008 and 2009, YH was the dominant 
haplotype in both years and YH was also dominant in the compli‑
cated malaria infections from 2007 to 2009
Table 2 Logistic regression analysis of  Rh5 YH and  HD 
alleles in  all three malaria infections between  2007 
and 2009
Haplotype Odds ratio (95 % CI) p value
YH HD
Age 1.1 (0.89–1.39) 0.349
Year
 2007 42 (54) 36 (46) 1
 2008 60 (68) 27 (31) 0.11 (0.03–0.37) <0.001
 2009 51 (80) 12 (19) 0.05 (0.01–0.29) 0.001
Population
 Severe 105 (73) 38 (27) 1
 Uncomplicated 25 (51) 24 (49) 4.66 (1.75–12.43) 0.002
 Asymptomatic 28 (68) 13 (32) 7.43 (1.57–35.16) 0.011
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administration were by parasites of the non-vaccine allele 
[17, 19]. Thus, similar to the scenario in this study, Rh5 
appears to show the same effect of post-treatment infec-
tions with predominantly an alternative allele after drug 
clearance. This variation may be reflected in the Rh5 
allele frequencies at a population level, providing the 
first possible explanation for the observed heterogeneity 
in Rh5 allele frequencies in the uncomplicated malaria 
Fig. 3 The distribution of PfRh5 YH and HD haplotypes in Kilifi County in the east of Kenya by the Indian Ocean. The map highlights the Kilifi health 
and demographic surveillance system (KHDSS). a The distribution of YH and HD haplotypes in all three malaria infection populations (uncompli‑
cated, asymptomatic, complicated) between 2007 and 2009. The years are represented by different symbols, triangle for 2007, circle for 2008 and 
square for 2009. b YH and HD haplotype distribution in 2007 showing a significant cluster (depicted by the red circle showing the region of the 
cluster) in the north of the KHDSS that contains more YH alleles compared to the parasites from the south (relative risk = 2, p = 0.0024) using the 
SaTScan software. c YH and HD allele distribution in 2008; and, d YH and HD haplotype distribution in 2009. The black cross indicates the health 
centres Kilifi District Hospital, Junju and Pingilikani dispensaries. The alleles are depicted as blue for HD and red for YH
Fig. 4 Rh5 haplotype frequency distribution in the complicated malaria infections over a ten‑year period. YH was the dominant haplotype from 
2000 to 2010
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infections. The temporal variation in selection of Rh5 
variants may be due to frequency-dependent selection, 
such that in this population of children with low lev-
els of acquired immunity, the rare YH variants in 2007 
have an advantage over the common HD variant and 
thus YH rises to high frequency in 2008. Furthermore, 
in the asymptomatic and complicated malaria infections 
the Rh5 alleles were temporally maintained at stable fre-
quencies, also suggesting frequency-dependent selection. 
Therefore, at an individual level, allele frequencies may 
change between infections but at a population level they 
even out into stable frequencies over time. Since all indi-
viduals will eventually encounter all Rh5 variants, the ini-
tially rare variant will rise in frequency until equilibrium 
is attained between all circulating variants.
The second, plausible reason is provided by evidence 
of differences in clinical outcome, such that children who 
presented with uncomplicated or asymptomatic malaria 
were more likely to be infected with HD allele parasites 
than those with complicated malaria infections. The het-
erogeneity in selection pressures may therefore be due to 
differences in the levels of acquired immunity in the indi-
viduals with mild and complicated malaria. The variation 
in the spectrum of disease from asymptomatic to com-
plicated or severe malaria has previously been described 
and it was primarily attributed to prior exposure and 
acquired immunity [49].
The third explanation may be as a result of the evidence 
of spatial patterns of selection in 2007 of a difference in 
allele frequencies between the north and south of Kilifi 
County, with more HD infecting parasites in the south 
compared to the north. These allele frequency differences 
may be a result of the differences in malaria transmission, 
which is low in the north and moderate to high in the 
south [50], and this would alter the levels of immunity of 
individuals in both regions. A previous study in Senegal, 
showed higher immune responses to recombinant Rh5 
protein in a high malaria transmission area compared to 
a lower transmission region [51]. Therefore, it is possi-
ble that there is selection for more variants in the higher 
transmission areas and we observed a higher frequency 
of the HD variant in the south of Kilifi. However, perhaps 
the missing data from the asymptomatic malaria infec-
tions in 2007, also from the south, which was expected 
from the observed stable frequencies in 2008 and 2009 to 
be predominantly YH, may have resulted in a sampling 
bias, resulting in the observed skew in allele frequencies. 
Nevertheless, the data do provide evidence that fluctuat-
ing selection may maintain the variation in Rh5 polymor-
phisms in the uncomplicated malaria population.
The fourth and more extreme hypothesis is that the fluc-
tuation in Rh5 allele frequencies may be a result of a para-
site population bottleneck effect, which greatly reduced 
the parasite population harbouring the HD allele, perhaps 
by some variation in transmission intensity that altered 
the allele frequency over time. However, it may simply be 
a case of genetic drift in a small localized population that 
results in the random fluctuations in allele frequencies.
The stable Rh5 allele frequencies in the complicated 
malaria infections were maintained over a ten-year 
period on a backdrop of changes in the host population 
demography. An increase over time of more children 
coming from the south who are older (>5  years) and a 
decrease in cerebral malaria cases over time. Suggesting 
therefore, that even a change over time in the infected 
host population dynamics does not alter the frequency 
of Rh5 polymorphisms, perhaps due to the fact that the 
constant selection pressure is the immune pressure from 
these individuals. Thus, even though there is a shift to an 
older age group at a population level, all the individuals 
still encounter all Rh5 variants, maintaining a stable allele 
frequency over time.
Overall, the stable and fluctuating Rh5 polymorphism 
frequencies appear to be the result of the host’s ability to 
mount an immune response to prevent infection, and it 
may be the major driving force maintaining the Rh5 poly-
morphisms in codons 147 and 148. Furthermore, the Rh5 
laboratory strain sequences were similar to each other 
except for the Palo Alto strain, however they differ greatly 
from the field isolates which contain SNPs in codons 147 
and 148. These SNPs were not observed in the laboratory 
strains.
Recently, the partial Rh5 protein structure has been 
described [52], which suggests that codons 147 and 148 
fall outside the basigin-binding region. They may sim-
ply be involved in evading host immune responses and 
redirecting the immune system away from the important 
functional binding regions of the protein. Previous stud-
ies have demonstrated that Rh5 may be a poorly immu-
nogenic antigen or the responses may be short lived 
[53, 54] and immune responses are likely to be allele-
transcending [47, 54]. Yet, this study potentially sug-
gests that immunity may maintain the high frequency 
of the polymorphisms in codons 147 and 148. Although 
the observed allele changes in Rh5 are at a genetic level, 
the functional impact of the polymorphisms remains to 
be determined, since cross-strain neutralizing antibodies 
have previously been demonstrated in vitro [53].
The LD analysis examined the impact of the potential 
interactions between the 15 merozoite antigens, identify-
ing polymorphic combinations between different genes 
that may be favoured and maintained by natural selec-
tion, potentially due to epistatic selection [55, 56]. Rh5 
appears to contain SNPs in LD with SNPs in EBA175 
and Rh2a. This interaction between the polymorphisms 
of different merozoite loci may be due to a functional 
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relationship, providing a fitness advantage such as evad-
ing the immune system or invading erythrocytes and 
emphasizing the overall complex nature of merozoite 
invasion [57] or immune evasion.
Conclusions
The shift in allele frequencies at a population level and in 
individual infections, pre- and post-treatment, seemed 
to only have an impact on the pattern of Rh5 genetic 
diversity and codons 147 and 148 may be genetic mark-
ers of immune pressure—not to level that results in 
allele-specific immune responses. However, perhaps an 
increase in sample size, and an extension of the uncom-
plicated and asymptomatic malaria parasite population 
analyses back to 2005 would identify more antigens 
operating under the same principle of both fluctuating 
and stable allele frequencies over time. Additionally, the 
authors note the lack of microsatellite analyses as a limi-
tation, since it would help to confirm unique genotypes 
and ascertain that the allele frequency changes were lim-
ited to the Rh5 locus. Nonetheless, this study provides 
crucial data describing potential selection forces main-
taining Rh5 polymorphisms in the population on a tem-
poral context. It would also be important to determine 
whether the Rh5 variants elicit an immune response 
in this genotyped population, to determine the exact 
mechanism maintaining the polymorphisms in this 
population.
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